Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[INITIAL EXPERIENCE OF THE ENZALUTAMIDE TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER].
Igarashi A, Fukagai T, Morita M, Hayashi K, Koshikiya A, Ogawa Y, Fuji K, Naoe M, Morita J, Oshinomi K, Nakazato T, Ogawa Y, Matsui Y, Shimada M, Inoue K, Saito K, Ogawa Y, Matsumoto Y, Sasaki H, Ota M, Yamamoto K, Shimoyama H, Imamura Y, Yamagishi M, Tanifuji S, Ishihara M, Shichijyo T, Sato N, Omori K, Matsubara E. Igarashi A, et al. Among authors: shimoyama h. Nihon Hinyokika Gakkai Zasshi. 2016;107(3):155-161. doi: 10.5980/jpnjurol.107.155. Nihon Hinyokika Gakkai Zasshi. 2016. PMID: 28740046 Free article. Japanese.
Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas.
Nakasato T, Hiramatsu A, Matsui Y, Unoki T, Shimoyama H, Oshinomi K, Morita J, Maeda Y, Naoe M, Fuji K, Ogura H, Homma M, Yamochi T, Takimoto M, Ogawa Y. Nakasato T, et al. Among authors: shimoyama h. Cancer Treat Res Commun. 2018;17:23-30. doi: 10.1016/j.ctarc.2018.10.003. Epub 2018 Oct 9. Cancer Treat Res Commun. 2018. PMID: 30326420 Free article.
Current Status of Sequential Treatment for Castration-resistant Prostate Cancer: A Retrospective Analysis.
Oshinomi K, Mugita T, Inoue T, Omizu M, Yamagishi M, Nakagami Y, Nagata M, Shimoyama H, Ota M, Morita J, Sasaki H, Matsubara E, Saito K, Fuji K, Morita M, Fukagai T. Oshinomi K, et al. Among authors: shimoyama h. Cancer Diagn Progn. 2025 Jan 3;5(1):56-61. doi: 10.21873/cdp.10412. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758244 Free PMC article.
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.
Kikuchi E, Hayakawa N, Nakayama M, Uno M, Nakatsu H, Kitagawa C, Miyake H, Yamada T, Fujita K, Shimoyama H, Nishihara K, Kobayashi M, Nakamura M, Fujimoto K, Sano T, Nishiyama N, Ito T, Kajita M, Kobayashi T, Kitamura H. Kikuchi E, et al. Among authors: shimoyama h. Int J Urol. 2024 Aug;31(8):859-867. doi: 10.1111/iju.15473. Epub 2024 May 9. Int J Urol. 2024. PMID: 38722221 Free PMC article.
Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry.
Suwa M, Morii I, Kino M, Matsui Y, Yoshinaga M, Takahashi H, Takagi M, Yoshida A, Ichikawa M, Nakajima O, Tanimura M, Shimoyama H, Saitoh H, Sasaki I, Suzuki T, Uemae S. Suwa M, et al. Among authors: shimoyama h. Pharmaceuticals (Basel). 2024 Oct 25;17(11):1431. doi: 10.3390/ph17111431. Pharmaceuticals (Basel). 2024. PMID: 39598343 Free PMC article.
141 results